Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) Capital Expenditures (2009 - 2026)

Evotec SE's (EVO) quarterly Capital Expenditures came in at -$4.9 million in Q1 2026, up 74.54% year-over-year from -$2.8 million in Q1 2025, and up 88.88% quarter-over-quarter from -$43.8 million in Q4 2025.

Analysis

Evotec SE (EVO) Capital Expenditures (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Capital Expenditures across 9 years of filings, most recently posting -$4.9 million for Q1 2026.

  • In Q1 2026, Capital Expenditures rose 74.54% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$94.3 million (up 8.22% YoY), while the FY2025 annual figure was -$82.0 million, up 35.54% from the prior year.
  • Capital Expenditures came in at -$4.9 million for Q1 2026 at Evotec SE, up from -$43.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $82.2 million in Q3 2022 to a low of -$229.4 million in Q4 2023.
  • Average Capital Expenditures over 5 years is -$48.5 million, with a median of -$33.7 million recorded in 2024.
  • Year-over-year, Capital Expenditures sank 109924.74% in 2022 and soared 196.05% in 2023.
  • Over 5 years, Capital Expenditures stood at -$185.2 million in 2022, then retreated by 23.85% to -$229.4 million in 2023, then surged by 92.92% to -$16.2 million in 2024, then sank by 169.69% to -$43.8 million in 2025, then surged by 88.88% to -$4.9 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were -$4.9 million in Q1 2026, -$43.8 million in Q4 2025, and -$23.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 23.91 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -42.42 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 31.11 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 9.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 2.62 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 125,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.87 Mn
Dec 31, 2025 -43.81 Mn
Sep 30, 2025 -23.63 Mn
Jun 30, 2025 -22.00 Mn
Mar 31, 2025 -19.14 Mn
Dec 31, 2024 -16.24 Mn
Sep 30, 2024 -29.41 Mn
Jun 30, 2024 -37.96 Mn
Mar 31, 2024 -43.71 Mn
Dec 31, 2023 -229.36 Mn
Jun 30, 2023 -160.23 Mn
Mar 31, 2023 46.27 Mn
Dec 31, 2022 -185.19 Mn
Sep 30, 2022 82.20 Mn
Jun 30, 2022 -41.03 Mn
Mar 31, 2022 -48.17 Mn
Dec 31, 2021 -250.67 Mn
Sep 30, 2021 32.56 Mn
Jun 30, 2021 87.44 Mn
Mar 31, 2021 -43,782.75